APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Active, not recruiting

Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to evaluate the APIXABAN use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation in Real-Life Setting in France, data from SNIIRAM (French data base).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 August 2017.

30 Jun 2013 22 Dec 2015 15 Nov 2017 15 Nov 2017 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample

Contacts

Not available